Does early administration of selenium improve outcome after cardiopulmonary resuscitation?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011493

Enrollment

Registered

2017-01-12

Start date

2009-10-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I46.0

Interventions

Group 1: Selenium administration < 72 hours after ROSC Group 2: No selenium administration

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - CPR following cardiac arrest of any cause, in- or out-of-hospital - age > 18 years - duration of CPR of at least 5 minutes - selenium administration in therapeutic dosage of any cause within 72 hours after ROSC

Exclusion criteria

Exclusion criteria: - CPR following cardiac arrest of any cause, in- or out-of-hospital - age > 18 years - duration of CPR of at least 5 minutes - selenium administration in therapeutic dosage of any cause within 72 hours after ROSC

Design outcomes

Primary

Measure	Time frame
Primary endpoint: Course of selenium plasma levels in resuscitated patients on day 1, 2, 3 after CPR	—

Secondary

Measure	Time frame
secondary endpoint: Outcome: - Survival to discharge from ICU - neurological performance	—

Countries

Germany

Contacts

Public ContactKatrin Fink

Universitätsklinikum Freiburg

katrin.fink@uniklinik-freiburg.de004976127033300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026